Reconstruction Kinetics of γδ T Cells After Unrelated Cord Blood Transplantation
NCT07782684 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2026-08-24
Summary
The primary objective is to investigate the correlation between specific patterns of γδ T cell reconstitution after umbilical cord blood transplantation and key clinical outcomes.
Conditions
- Hematologic Disease and Disorders
Interventions
- PROCEDURE
-
Umbilical Cord Blood Transplantation as Treatment of Adult Patients with Hematologic Disorders
Allogeneic umbilical cord blood transplantation as a standard treatment for underlying hematological diseases.
Sponsors & Collaborators
-
Anhui Provincial Hospital
lead OTHER_GOV
Principal Investigators
-
Xiao yu Zhu, ph.D · The First Affiliated Hospital of University of Science and Technology of China
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-10-09
- Primary Completion
- 2026-11-01
- Completion
- 2030-10-01
Countries
- China
Study Locations
More Related Trials
-
A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia
NCT06729320 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Collection and Storage of Umbilical Cord Blood for Transplantation
NCT01728545 ·Status: RECRUITING
-
Intra Bone Marrow Injection Of Unrelated Cord Blood Cells
NCT00696046 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Adult Double Cord Blood Transplant Study
NCT00514579 ·Status: COMPLETED ·Phase: PHASE2
-
Umbilical Cord Transplantation for the Elderly Population
NCT01484470 ·Status: COMPLETED ·Phase: PHASE2
-
Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia
NCT04174586 ·Status: UNKNOWN ·Phase: PHASE1
-
Reduction of Cord Blood Transplantation Toxicity in Patients With Acute Myeloid Leukemia
NCT00797758 ·Status: COMPLETED ·Phase: PHASE2
-
UARK 2006-28 Human Cord Blood Transplantation in Advanced Hematological Malignancies
NCT00578045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT
NCT05290545 ·Status: COMPLETED ·Phase: PHASE3
-
Unrelated Umbilical Cord Blood Transplantation With Coinfusion of Mesenchymal Stem Cells
NCT01092026 ·Status: COMPLETED ·Phase: NA
-
Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation
NCT00737516 ·Status: COMPLETED ·Phase: PHASE2
-
Studying Umbilical Cord Blood From African-American Donors
NCT00717535 ·Status: WITHDRAWN
-
Immune Reconstitution in Stem Cell Transplant Recipients
NCT02129543 ·Status: RECRUITING
-
The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation
NCT06792682 ·Status: RECRUITING ·Phase: PHASE1
-
Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant
NCT02668315 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Umbilical Cord Blood Transfusion in Consolidation Therapy of Elderly Patients With Acute Myeloid Leukemia
NCT04687657 ·Status: UNKNOWN ·Phase: PHASE1
-
The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients
NCT02069210 ·Status: UNKNOWN
-
Cord Blood Transplantation in Severe Aplastic Anemia
NCT01343953 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies
NCT02386332 ·Status: UNKNOWN
-
Transfusion Requirements in Surgical Oncologic Patient
NCT01502215 ·Status: COMPLETED ·Phase: PHASE3
-
Unrelated Umbilical Cord Blood (UBC)Transplantation
NCT01768845 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing Single Versus Double Umbilical Cord Blood Transplantation in the Young With Acute Leukemia Remission
NCT01067300 ·Status: UNKNOWN ·Phase: PHASE3
-
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells
NCT00770523 ·Status: COMPLETED
-
Donor Neutrophil Subsets to Predict the Risk of aGVHD
NCT06394895 ·Status: ACTIVE_NOT_RECRUITING